Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06284590
What this trial is testing

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Philogen S.p.A. 162
Early research (Phase 1)Study completedNCT01709435
What this trial is testing

Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Recurrent Malignant Solid NeoplasmRecurrent MelanomaRecurrent Primary Central Nervous System Neoplasm+4 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT00219843
What this trial is testing

Intralesional PV-10 Chemoablation of Metastatic Melanoma

Who this might be right for
Melanoma
Provectus Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT00054535
What this trial is testing

Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Not applicableWithdrawnNCT02507076
What this trial is testing

Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

Who this might be right for
Basal Cell Carcinoma of the SkinEccrine Carcinoma of the SkinRecurrent Adult Soft Tissue Sarcoma+8 more
Albert Einstein College of Medicine
Not applicableStudy completedNCT04164550
What this trial is testing

Interpolated Flap Study

Who this might be right for
Skin Cancer, Non-MelanomaSkin Cancer MelanomaMohs Micrographic Surgery
University of Pennsylvania 170
Early research (Phase 1)Ended earlyNCT02974725
What this trial is testing

A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma

Who this might be right for
Non-Small Cell Lung CancerMelanoma
Novartis Pharmaceuticals 241
Large-scale testing (Phase 3)Not Yet RecruitingNCT07815574
What this trial is testing

ISCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma

Who this might be right for
Melanoma (Skin Cancer)Advanced MelanomaMetastatic Melanoma+1 more
Scancell Ltd 550
Testing effectiveness (Phase 2)Ended earlyNCT04902040
What this trial is testing

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Who this might be right for
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Ended earlyNCT02314143
What this trial is testing

Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib

Who this might be right for
Melanoma
GlaxoSmithKline 48
Testing effectiveness (Phase 2)Ended earlyNCT02974803
What this trial is testing

Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases

Who this might be right for
MelanomaBrain Metastases
Canadian Cancer Trials Group 6
Testing effectiveness (Phase 2)Looking for participantsNCT07644897
What this trial is testing

Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma

Who this might be right for
MelanomaImmune-related Adverse EventImmune Checkpoint Inhibitor
Sun Yat-sen University 55
Not applicableUnknownNCT04842279
What this trial is testing

FACE-Q in Facial Reconstructive Surgery: A Prospective Database

Who this might be right for
Skin Cancer, Basal Cell Skin Cancer Skin Cancer, Non-Melanoma Skin Cancers - Squamous Cell Carcinoma Patient Satisfaction
McMaster University 300
Large-scale testing (Phase 3)Study completedNCT02714218
What this trial is testing

Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 387
Testing effectiveness (Phase 2)UnknownNCT00111046
What this trial is testing

Pain Relief - Tramadol Versus Ibuprofen

Who this might be right for
Choroidal MelanomaMelanomaEye Neoplasms
Royal Liverpool University Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT01721603
What this trial is testing

Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets

Who this might be right for
BRAFV600E Melanoma Patients
University of California, San Francisco 2
Not applicableLooking for participantsNCT06666790
What this trial is testing

DermaSensor Postmarket Surveillance Study

Who this might be right for
Melanoma, Skin
DermaSensor, Inc. 396
Not applicableUnknownNCT06236360
What this trial is testing

Metastatic Melanoma Patients on Immunotherapy With Nutritive Intervention Based on Mediterranean Diet

Who this might be right for
Melanoma Stage IvMetastatic Melanoma
University Hospital Rijeka 30
Not applicableActive Not RecruitingNCT04588662
What this trial is testing

A Prospective Natural History Study in Uveal Melanoma

Who this might be right for
Uveal Melanoma
Columbia University 122
Early research (Phase 1)Study completedNCT02613325
What this trial is testing

FPAM for the in Vivo Depth Measurement of Pigmented Lesions and Melanoma Depth

Who this might be right for
Pigmented Skin LesionMelanoma
Washington University School of Medicine 24
Next Page